CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: teniposide
Accession: CHEBI:75988
browse the term
Definition: A furonaphthodioxole that is a synthetic derivative of podophyllotoxin with anti-tumour activity; causes single- and double-stranded breaks in DNA and DNA-protein cross-links and prevents repair by topoisomerase II binding.
Synonyms: exact_synonym: (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-(thiophen-2-ylmethylidene)-beta-D-glucopyranoside
related_synonym: 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin-beta-D-thenylidene glucoside; Formula=C32H32O13S; HSDB 6546; InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31?,32-/m0/s1; InChIKey=NRUKOCRGYNPUPR-QBPJDGROSA-N; NSC-122819; SMILES=[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@@H]1O[C@]2([H])CO[C@]([H])(O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1; VM-26; VM26; Vumon; teniposido; teniposidum
alt_id: CHEBI:9917
xref: CAS:29767-20-2; DrugBank:DB00444; Drug_Central:2590; HMDB:HMDB0014587; KEGG:C11153; KEGG:D02698
xref_mesh: MESH:D013713
xref: MetaCyc:CPD-16755; PDBeChem:9TP; PMID:1063066; PMID:11516526; PMID:1329226; PMID:1411642; PMID:1411643; PMID:21430063; PMID:21821840; PMID:22644709; PMID:22771706; PMID:22846410; PMID:23266449; PMID:23466610; PMID:23679827; PMID:23838380; PMID:24969912; PMID:25151861; PMID:25448575; PMID:25899285; PMID:26253377; PMID:27596115; PMID:30409428; PMID:32015321; PMID:32194707; Reaxys:1417328; Wikipedia:Teniposide
G
Abcc1
ATP binding cassette subfamily C member 1
decreases response to substance
ISO
ABCC1 results in decreased susceptibility to Teniposide
CTD
PMID:8968083
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Ar
androgen receptor
multiple interactions
ISO
Teniposide binds to and results in decreased activity of AR protein
CTD
PMID:25752796
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Teniposide results in increased expression of CDKN1A mRNA; Teniposide results in increased expression of CDKN1A protein
CTD
PMID:25914138
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases methylation multiple interactions
ISO
CYP3A4 protein results in decreased methylation of Teniposide Cyclosporine inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]; Dexamethasone inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]; Erythromycin inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]; Midazolam inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]
CTD
PMID:8114683
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases methylation
ISO
CYP3A5 protein results in decreased methylation of Teniposide
CTD
PMID:8114683
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Teniposide binds to and results in decreased activity of ESR1 protein
CTD
PMID:25752796
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
ISO
Teniposide binds to and results in decreased activity of ESR2 protein
CTD
PMID:25752796
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Fgf2
fibroblast growth factor 2
decreases response to substance
ISO
FGF2 protein results in decreased susceptibility to Teniposide
CTD
PMID:20221717
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Teniposide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Mir135b
microRNA 135b
decreases response to substance
ISO
MIR135B mRNA results in decreased susceptibility to Teniposide
CTD
PMID:27570640
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
G
Mir196b
microRNA 196b
decreases response to substance
ISO
MIR196B mRNA results in decreased susceptibility to Teniposide
CTD
PMID:27570640
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
G
Mttp
microsomal triglyceride transfer protein
decreases expression multiple interactions
ISO
Teniposide results in decreased expression of MTTP mRNA Teniposide promotes the reaction [CETP protein results in decreased expression of MTTP mRNA]
CTD
PMID:25914138
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Teniposide results in decreased expression of MYC mRNA; Teniposide results in decreased expression of MYC protein
CTD
PMID:11585056
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
multiple interactions affects response to substance affects localization
ISO
NR1H2 mutant form inhibits the reaction [Teniposide results in increased expression of CETP mRNA]; Teniposide promotes the reaction [NR1H2 protein results in increased expression of CETP mRNA] NR1H2 protein affects the susceptibility to Teniposide Teniposide affects the localization of NR1H2 protein
CTD
PMID:25914138
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions affects response to substance increases expression
ISO
NR1H3 mutant form inhibits the reaction [Teniposide results in increased expression of CETP mRNA]; Teniposide promotes the reaction [NR1H3 protein results in increased expression of CETP mRNA]; Teniposide results in increased expression of and affects the localization of NR1H3 protein NR1H3 protein affects the susceptibility to Teniposide Teniposide results in increased expression of NR1H3 mRNA
CTD
PMID:25914138
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nrip1
nuclear receptor interacting protein 1
decreases expression
ISO
Teniposide results in decreased expression of NRIP1 mRNA; Teniposide results in decreased expression of NRIP1 protein
CTD
PMID:25914138
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Odc1
ornithine decarboxylase 1
decreases expression
ISO
Teniposide results in decreased expression of ODC1 protein
CTD
PMID:11585056
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Pgr
progesterone receptor
multiple interactions
ISO
Teniposide binds to and results in decreased activity of PGR protein
CTD
PMID:25752796
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
Teniposide promotes the reaction [RXRA protein results in increased expression of CETP mRNA]; Tretinoin promotes the reaction [Teniposide promotes the reaction [RXRA protein results in increased expression of CETP mRNA]]
CTD
PMID:25914138
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
multiple interactions
ISO
Teniposide inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]
CTD
PMID:30863990
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Teniposide binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
Teniposide binds to and results in decreased activity of THRB protein
CTD
PMID:25752796
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
TOP2A results in decreased susceptibility to [Cisplatin co-treated with Teniposide]
CTD
PMID:11325482
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all